Analysis Of Htlv-I Proviral Load In 202 Ham/Tsp Patients And 243 Asymptomatic Htlv-I Carriers: High Proviral Load Strongly Predisposes To Ham/Tsp

References

• Ali A., Rudge P., Dalgleish A.G. Neopterin concentration in serum and cerebrospinal fluid in HTLV-I infected individuals. J Neurol 1992; 239: 270–272
   Google Scholar
• Dhawan S., Weeks B. S., Abbasi F, et al. Increased expression of alpha 4 beta 1 and alpha 5 beta 1 integrins on HTLV-I-infected lymphocytes. Virology 1993; 197: 778–781
   Google Scholar
• Eiraku N., Ijichi S., Yashiki S., et al. Cell surface phenotype of in vitro proliferating lymphocytes in HTLV-I-associated myelopathy (HAM/TSP). J Neuro-immunol 1992; 37: 223–228
   Google Scholar
• Furukawa Y., Fujisawa J., Osame M, et al. Frequent clonal proliferation of human T-cell leukemia virus type 1 (HTLV-l)-infected T cells in HTLV-1-associated myelopathy (HAM-TSP). Blood 1992; 80: 1012–1016
   PubMed Web of Science ®Google Scholar
• Gessain A., Barin F., Vernant JC., et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2: 407–410
   PubMed Web of Science ®Google Scholar
• Gessain A., Saal F., Gout O., et al. High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis. Blood 1990; 75: 428–433
   PubMed Web of Science ®Google Scholar
• Harrington W. J., Jr, Sheremata W. A., Snodgrass S.R., et al. Tropical spastic paraparesis/HTLV-1-asso-ciated myelopathy (TSP/HAM): treatment with an anabolic steroid danazol. AIDS Res Hum Retrovirus 1991; 7: 1031–1034
   PubMed Web of Science ®Google Scholar
• Hashimoto K., Higuchi I., Osame M, et al. Quantitative in situ PCR assay of HTLV-I infected cells in peripheral blood lymphocytes of patients with ATL, HAM/TSP and asymptomatic carriers. J Neurol Sci, 159: 67–72
   Google Scholar
• Heid C. A., Stevens J., Livak K. J., Williams P.M. Real time quantitative PCR. Genome Res 1996; 6: 986–994
   PubMed Web of Science ®Google Scholar
• Hollsberg P., Hafler D.A. What is the pathogenesis of human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis?. Ann Neurol 1995; 37: 143–145
   Google Scholar
• Ichinose K., Nakamura T., Kawakami A., et al. Increased adherence of T cells to human endothelial cells in patients with human T-cell lymphotropic virus type I-associated myelopathy. Arch Neurol 1992; 49: 74–76
   PubMed Web of Science ®Google Scholar
• Ichinose K., Nakamura T., Nishiura Y., et al. Characterization of adherent T cells to human endothelial cells in patients with HTLV-I-associated myelopathy. J Neurol Sci 1994; 122: 204–209
   Google Scholar
• Ijichi S., Izumo S., Eiraku N., et al. An auto-aggressive process against bystander tissues in HTLV-I-infected individuals: a possible pathomechanism of HAM/TSP. Med Hypotheses 1993; 41: 542–547
   Google Scholar
• Itoyama Y., Minato S., Kira J., et al. Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy. Neurology 1988; 38: 1302–1307
   PubMed Web of Science ®Google Scholar
• Izumo S., Ijichi T., Higuchi I, et al. Neuropathology of HTLV-I-associated myelopathy-a report of two autopsy cases. Acta Paediatr Jpn 1992; 34: 358–364
   PubMedGoogle Scholar
• Jacobson S., Zaninovic V., Mora C, et al. Immunological findings in neurological diseases associated with antibodies to HTLV-I: activated lymphocytes in tropical spastic paraparesis. Ann. Neurol 1988; 23((Suppl))S196–S200
   Google Scholar
• Jacobson S., Shida H., McFarlin DE, et al. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 1990; 348: 245–248
   PubMed Web of Science ®Google Scholar
• Jacobson S. Cellular immune responses to HTLV-I: immunopathogenic role in HTLV-I-associated neurologic disease. J Acquir Immune Defic Syndr Hum Retroviral 1996; 13: S100–S106
   Google Scholar
• Kaplan J. E., Osame M., Kubota H., et al. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr 1990; 3: 1096–1101
   PubMed Web of Science ®Google Scholar
• Khabbaz R. F., Onorato I. M., Cannon RO., et al. Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med 1992; 326: 375–380
   PubMed Web of Science ®Google Scholar
• Kira J., Koyanagi Y., Yamada T., et al. Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study. Ann Neurol 1991; 29: 194–201
   PubMed Web of Science ®Google Scholar
• Kubota R., Fujiyoshi T., Izumo S., et al. Fluctuation of HTLV-I provirol DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy. J Neuroimmunol 1993; 42: 147–154
   Google Scholar
• Machigashira K., Ijichi S., Nagai M., et al. In vitro virus propagation and high cellular responsiveness to the infected cells in patients with HTLV-I-associated myelopathy (HAM/TSP). J Neurol Sci 1997; 149: 141–145
   Google Scholar
• Matsuoka E., Takenouchi N., Hashimoto K., et al. Perivascular T-cells are infected with HTLV-I in the spinal cord lesions with HAM/TSP: Double staining of immunohistochemistry and PCR in situ hybridization. Acta Neuropathy Bed 1998; 96: 340–346
   PubMed Web of Science ®Google Scholar
• Mellors J. W., Munoz A., Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern Med 1997; 126: 946–954
   Google Scholar
• Melo A., Moura L., Meireles A., Costa G, Danazol. A new perspective in the treatment of HTLV-1 associated myelopathy (preliminary report). Arq-Neuro-psiquiatr 1992; 50: 402–403
   Google Scholar
• Moritoyo T., Reinhart T. A., Moritoyo H, et al. Human T-lumphotropic virus type I-associated myelopathy and tax gene expression in CD4+ T lymphocytes. Ann Neurol 1996; 40: 84–90
   PubMedGoogle Scholar
• Nagai M., Yashiki S., Fujiyoshi T, et al. Characterization of a unique T-cell clone established from a patient with HAM/TSP which recognized HTLV-I-infected T-cell antigens as well as spinal cord tissue antigens. J Neuroimmunol 1996; 65: 97–105
   Google Scholar
• Nomoto M., Utatsu Y., Soejima Y., Osame M. Neopterin in cerebrospinal fluid: a useful marker for diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis. Neurology 1991; 41: 457
   Google Scholar
• O'Brien W. A., Hartigan P. M., Martin D, et al. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. TV. Engl J Med 1996; 334: 426–431
   PubMed Web of Science ®Google Scholar
• Osame M., Usuku K., Izumo S., et al. HTLV-I associated myelopathy, a new clinical entity [letter]. Lancet 1986; 1: 1031–1032
   PubMed Web of Science ®Google Scholar
• Osame M., Matsumoto M., Usuku K, et al. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann Neurol 1987; 21: 117–122
   PubMed Web of Science ®Google Scholar
• Osame M. Human Retrovirology: HTLV. Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP, W.A. Blattner. Raven Pres, New York 1990; 191–197
   Google Scholar
• Osame M., Janssen R., Kubota H, et al. Nationwide survey of HTLV-I-associated myelopathy in Japan: Association with blood transfusion. Ann Neurol 1990a; 28: 50–56
   PubMed Web of Science ®Google Scholar
• Parker C. E., Daenke S., Nightingale S., Bangham C.R. Activated HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology 1992; 188: 628–636
   PubMed Web of Science ®Google Scholar
• Saag M. S., Holodniy M., Kuritzkes DR, et al. HIV viral load markers in clinical practice. Nat Med 1996; 2: 625–629
   PubMed Web of Science ®Google Scholar
• Sonoda S., Yashiki S., Takahashi K, et al. Altered HLA antigens expressed on T and B lymphocytes of adult T-cell leukemia/lymphoma patients and their relatives. Int J Cancer 1987; 40: 629–634
   Google Scholar
• Tateno M. Rat lymphoid cell lines producing human T cell leukemia virus-I. Hokkaido Igaku Zasshi 1987; 62: 74–81
   Google Scholar
• Umehara F., Izumo S., Nakagawa M, et al. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 1993; 52: 424–430
   Google Scholar
• Umehara F., Izumo S., Ronquillo AT, et al. Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 1994; 53: 72–77
   PubMedGoogle Scholar
• Usuku K., Sonoda S., Osame M, et al. HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: comparison with adult T-cell leukemia/lymphoma. Ann Neurol 1988; 23((Suppl))S143–S150
   Google Scholar
• Yoshida M., Osame M., Kawai H, et al. Increased replication of HTLV-I in HTLV-I-associated myelopathy. Ann Neurol 1989; 26: 331–335
   PubMed Web of Science ®Google Scholar